Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2015

01.04.2015 | Maternal-Fetal Medicine

Diastolic blood pressure increase is a risk indicator for pre-eclampsia

verfasst von: Maria Bullarbo, Ragnar Rylander

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Objectives

A previous study demonstrated that the increase in diastolic blood pressure during pregnancy was reduced by supplementation with magnesium. The present study was undertaken to explore if increases in diastolic blood pressure could be useful for early identification of pre-eclampsia.

Study design

Hospital records of nulliparous, singleton normal pregnancies (n = 100) and those diagnosed with pre-eclampsia (n = 109) were obtained from a register at an antenatal health care unit. Data on blood pressure at the regular visits to the unit were collected and analysed.

Results

The systolic and diastolic blood pressures were significantly higher at pregnancy week 12 among those who developed pre-eclampsia (p = 0.046 and 0.001, resp). An increase in diastolic blood pressure ≥15 mmHg occurred more frequently among women with pre-eclampsia. In 93 % of the cases, this increase was present before and at the same time as the clinical diagnosis of pre-eclampsia was established.

Conclusion

The results suggest that a base-line diastolic blood pressure of ≥80 mmHg and an increase in diastolic blood pressure of ≥15 mmHg could be used to identify women at risk of pre-eclampsia (sensitivity 92 %, specificity 44 %) and as a selection criterion in treatment or prevention assays.
Literatur
1.
Zurück zum Zitat Gifford RW, August PA, Cunningham G et al (2000) Report of the national high blood pressure program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 183:S1–S22 Gifford RW, August PA, Cunningham G et al (2000) Report of the national high blood pressure program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 183:S1–S22
2.
Zurück zum Zitat Backes CH, Markham K, Moorehead P, Cordero L, Nankervis CA, Giannone PJ (2011) Maternal preeclampsia and neonatal outcomes. J Pregnancy. doi:10.1155/2011/214365 Backes CH, Markham K, Moorehead P, Cordero L, Nankervis CA, Giannone PJ (2011) Maternal preeclampsia and neonatal outcomes. J Pregnancy. doi:10.​1155/​2011/​214365
3.
Zurück zum Zitat Duley L (2009) The global impact of pre-eclampsia and eclampsia. Semin Perinatol 33:130–137CrossRefPubMed Duley L (2009) The global impact of pre-eclampsia and eclampsia. Semin Perinatol 33:130–137CrossRefPubMed
4.
Zurück zum Zitat Tranquilli AL, Brown MA, Zeeman GG, Dekker G, Sibai BM (2013) The definition of severe and early-onset preeclampsia. Statements from the international society for the study of hypertension in pregnancy (ISSHP). Pregn Hyperten 3:44–47 Tranquilli AL, Brown MA, Zeeman GG, Dekker G, Sibai BM (2013) The definition of severe and early-onset preeclampsia. Statements from the international society for the study of hypertension in pregnancy (ISSHP). Pregn Hyperten 3:44–47
5.
6.
Zurück zum Zitat Gilstrap LC III, Ramin SM (2002) Diagnosis and management of preeclampsia and eclampsia. ACOG Pract Bull 33:1–9 Gilstrap LC III, Ramin SM (2002) Diagnosis and management of preeclampsia and eclampsia. ACOG Pract Bull 33:1–9
7.
Zurück zum Zitat Tranquilli AL, Landi B, Giannubilo SR, Sibai BM (2012) Preeclampsia: No longer solely a pregnancy disease. Pregn Hyperten 2:350–357 Tranquilli AL, Landi B, Giannubilo SR, Sibai BM (2012) Preeclampsia: No longer solely a pregnancy disease. Pregn Hyperten 2:350–357
8.
Zurück zum Zitat Fayyad AM, Harrington KF (2005) Prediction and prevention of preeclampsia and IUGR. Early Human Dev 81:865–876CrossRef Fayyad AM, Harrington KF (2005) Prediction and prevention of preeclampsia and IUGR. Early Human Dev 81:865–876CrossRef
9.
Zurück zum Zitat Page EW, Christianson R (1976) The impact of mean arterial pressure in the middle trimester upon the outcome of pregnancy. Am J Obstet Gynecol 125:740–745PubMed Page EW, Christianson R (1976) The impact of mean arterial pressure in the middle trimester upon the outcome of pregnancy. Am J Obstet Gynecol 125:740–745PubMed
10.
Zurück zum Zitat Khalil A (2011) First trimester screening for pre-eclampsia. Pregn Hyperten 1:243 Khalil A (2011) First trimester screening for pre-eclampsia. Pregn Hyperten 1:243
11.
Zurück zum Zitat Thangaratinam S, Langenveld J, Mol BW, Khan KS (2011) Prediction and primary prevention of pre-eclampsia. Best Pract Res Clin Obstet Gynaecol 25:419–433CrossRefPubMed Thangaratinam S, Langenveld J, Mol BW, Khan KS (2011) Prediction and primary prevention of pre-eclampsia. Best Pract Res Clin Obstet Gynaecol 25:419–433CrossRefPubMed
12.
Zurück zum Zitat Coomarasamy A, Honest H, Papaioannuo et al (2003) Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol 101:1319–1332 Coomarasamy A, Honest H, Papaioannuo et al (2003) Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol 101:1319–1332
13.
Zurück zum Zitat Hofmeyr GJ, Atllah AN, Duley L (2006) Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 3:CD0011059 Hofmeyr GJ, Atllah AN, Duley L (2006) Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 3:CD0011059
14.
Zurück zum Zitat Mello G, Parretti E, Fatini C et al (2005) Low molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension 45:86–91CrossRefPubMed Mello G, Parretti E, Fatini C et al (2005) Low molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension 45:86–91CrossRefPubMed
16.
Zurück zum Zitat Bullarbo M, Ödman N, Nestler A, Nielsen Y, Kolisek M, Vormann J, Rylander R (2013) Magnesium supplementation to prevent high blood pressure in pregnancy—a randomised placebo control trial. Arch Obstet Gynecol 288:1269–1274CrossRef Bullarbo M, Ödman N, Nestler A, Nielsen Y, Kolisek M, Vormann J, Rylander R (2013) Magnesium supplementation to prevent high blood pressure in pregnancy—a randomised placebo control trial. Arch Obstet Gynecol 288:1269–1274CrossRef
17.
Zurück zum Zitat Nakamoto O, Tasaka R, Motohisa C (2012) Eclampsia with progressing disease correlates to severe diastolic blood pressure. Pregn Hypertens 2:180 Nakamoto O, Tasaka R, Motohisa C (2012) Eclampsia with progressing disease correlates to severe diastolic blood pressure. Pregn Hypertens 2:180
18.
Zurück zum Zitat Levine RJ, Ewell MG, Hauth JC et al (2000) Should the definition of preeclampsia include a rise in diastolic blood pressure of ≥15 mm Hg to a level of <90 mm Hg in association with proteinuria? Am J Obstet Gynecol 183:787–792CrossRefPubMed Levine RJ, Ewell MG, Hauth JC et al (2000) Should the definition of preeclampsia include a rise in diastolic blood pressure of ≥15 mm Hg to a level of <90 mm Hg in association with proteinuria? Am J Obstet Gynecol 183:787–792CrossRefPubMed
19.
Zurück zum Zitat Gifford RW (2000) Report of the National High Blood Pressure Education Program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 183:S1–S22CrossRef Gifford RW (2000) Report of the National High Blood Pressure Education Program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 183:S1–S22CrossRef
20.
Zurück zum Zitat Li S, Tian H (1997) Oral low dose magnesium gluconate preventing pregnancy induced hypertension. Chin J Obstet Gynaecol 32:613–615 Li S, Tian H (1997) Oral low dose magnesium gluconate preventing pregnancy induced hypertension. Chin J Obstet Gynaecol 32:613–615
21.
Zurück zum Zitat D’Almeida A, Carter JP, Anatol A, Prost C (1992) Effects of a combination of evening primrose oil (gamma linolenic acid) and fish oil (eicosapentaenoic + doca hexaenoic acid) versus magnesium, and versus placebo in preventing pre-eclampsia. Women Health 19:117–131CrossRefPubMed D’Almeida A, Carter JP, Anatol A, Prost C (1992) Effects of a combination of evening primrose oil (gamma linolenic acid) and fish oil (eicosapentaenoic + doca hexaenoic acid) versus magnesium, and versus placebo in preventing pre-eclampsia. Women Health 19:117–131CrossRefPubMed
22.
Zurück zum Zitat Sibai BM, Villar MA, Brazy E (1989) Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial. Am J Obstet Gynecol 161:115–119CrossRefPubMed Sibai BM, Villar MA, Brazy E (1989) Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial. Am J Obstet Gynecol 161:115–119CrossRefPubMed
Metadaten
Titel
Diastolic blood pressure increase is a risk indicator for pre-eclampsia
verfasst von
Maria Bullarbo
Ragnar Rylander
Publikationsdatum
01.04.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2015
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-014-3476-1

Weitere Artikel der Ausgabe 4/2015

Archives of Gynecology and Obstetrics 4/2015 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.